-
Symbol
-
ACRS on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.00001 per share
-
Latest Disclosed Ownership
-
14.3M shares
-
Security Ownership
-
13.3%
BML Investment Partners, L.P. ownership in Aclaris Therapeutics, Inc. Common Stock, par value $0.00001 per share (ACRS)
2025-02-13 - BML Investment Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 14.3M shares of Aclaris Therapeutics, Inc. Common Stock, par value $0.00001 per share (ACRS).
This represents 13.3% percent ownership of the company.